Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-Peptidase 4 Inhibitors”

167 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 167 results

Post-approval studies (Phase 4)Ended earlyNCT02048904
What this trial is testing

Use of Sitagliptin to Decrease Microalbuminuria

Who this might be right for
Type 2 DiabetesMicroalbuminuria
University of Missouri-Columbia 142
Large-scale testing (Phase 3)Ended earlyNCT04371978
What this trial is testing

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Who this might be right for
COVID 19CoronavirusDiabetes Mellitus, Type 2+12 more
Rabin Medical Center 64
Large-scale testing (Phase 3)Study completedNCT01822548
What this trial is testing

Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Azienda Ospedaliero-Universitaria di Parma 64
Not applicableUnknownNCT04469582
What this trial is testing

The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors

Who this might be right for
Bullous Pemphigoid
University of Athens 113
Post-approval studies (Phase 4)UnknownNCT01339143
What this trial is testing

Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes

Who this might be right for
Diabetes MellitusOxidative Stress
Korea University Anam Hospital 80
Not applicableActive Not RecruitingNCT07198191
What this trial is testing

SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

Who this might be right for
Acute Myocardial Infarction (AMI)Type 2 Diabetes Mellitus (T2DM)
Yonsei University 200,000
Post-approval studies (Phase 4)UnknownNCT01337440
What this trial is testing

Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases

Who this might be right for
Type 2 Diabetes MellitusChronic Liver Disease
Kanazawa University 20
Testing effectiveness (Phase 2)Study completedNCT00111631
What this trial is testing

DPP-IV Inhibitor in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 218
Post-approval studies (Phase 4)Study completedNCT04654676
What this trial is testing

DPP4 Inhibitor on Glycemic Variability

Who this might be right for
Diabetes Mellitus, Type 2
University Malaysia Sarawak 12
Post-approval studies (Phase 4)UnknownNCT03458715
What this trial is testing

The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin

Who this might be right for
Type2 Diabetes
Mackay Memorial Hospital 120
Large-scale testing (Phase 3)Study completedNCT01009580
What this trial is testing

Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 447
Large-scale testing (Phase 3)Study completedNCT01189890
What this trial is testing

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 480
Large-scale testing (Phase 3)Ended earlyNCT00865592
What this trial is testing

Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusType 2 Diabetes
Phenomix 450
Post-approval studies (Phase 4)Ended earlyNCT02653131
What this trial is testing

The Use of DPP-4 Inhibitors in Short Bowel Syndrome

Who this might be right for
Short Bowel Syndrome
Stanley Dudrick's Memorial Hospital 8
Testing effectiveness (Phase 2)WithdrawnNCT04410341
What this trial is testing

The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients

Who this might be right for
Major Depressive Disorder
Sadat City University
Post-approval studies (Phase 4)Study completedNCT02653209
What this trial is testing

TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes
Royal Devon and Exeter NHS Foundation Trust 525
Post-approval studies (Phase 4)Study completedNCT02312063
What this trial is testing

Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Kansai Electric Power Hospital 48
Not applicableStudy completedNCT02312375
What this trial is testing

Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients

Who this might be right for
Diabetes MellitusHypertension
Seoul National University Hospital 46
Post-approval studies (Phase 4)Study completedNCT01235819
What this trial is testing

Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes
Command Hospital, India 20
Large-scale testing (Phase 3)Study completedNCT01122641
What this trial is testing

The Vascular Effects of Vildagliptin in Insulin Resistant Individuals

Who this might be right for
Insulin ResistanceMicrovascular Disease
Royal Devon and Exeter NHS Foundation Trust 15
Next Page